메뉴 건너뛰기




Volumn 6, Issue 1, 2007, Pages 85-97

The ERK and p38MAPK pathways as targets for anti-inflammatory therapy

Author keywords

ERK; Gene targeting; JNK; MAPK; MAPKAPK; p38; TPL2; TTP

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; 5 (2 AMINO 4 PYRIMIDINYL) 4 (4 FLUOROPHENYL) 1 (4 PIPERIDINYL)IMIDAZOLE; 5 (2,6 DICHLOROPHENYL) 2 (2,4 DIFLUOROPHENYLTHIO)PYRIMIDO[1,6 B]PYRIDAZIN 6 ONE; ANTIINFLAMMATORY AGENT; CEP 1347; CGP 57380; DORAMAPIMOD; FR 180204; IMMUNOMODULATING AGENT; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHATASE; R 130823; SB 252235; SCAFFOLD PROTEIN; SCIO 469; SEMAPIMOD; TPL2 KINASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 33847620289     PISSN: 18715230     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152307779939741     Document Type: Review
Times cited : (12)

References (158)
  • 152
    • 7244252846 scopus 로고    scopus 로고
    • Cao, H. Biochemistry, 2004, 43, 13724-38.
    • (2004) Biochemistry , vol.43 , pp. 13724-13738
    • Cao, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.